| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/06/1992 | DE4024530A1 Control of viral disease using bovine pancreatic nuclease(s) - for treatment of e.g. rabies, herpes, Epstein-Barr virus and cow-pox |
| 02/06/1992 | CA2087853A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 02/06/1992 | CA2087430A1 Stable pharmaceutical compositions containing a fibroblast growth factor |
| 02/06/1992 | CA2087100A1 Immunotherapeutic method of preventing or treating viral respiratory tract disease |
| 02/06/1992 | CA2086923A1 Vinylsulphonyl pristinamycin and preparation thereof |
| 02/05/1992 | EP0469985A1 Process for manufacturing von Willebrand factor having a very high purity |
| 02/05/1992 | EP0469520A2 Polyactide preparation and purification |
| 02/05/1992 | EP0469359A2 Method and product for the treatment of gastric disease |
| 02/05/1992 | EP0469156A1 Glutathione derivative |
| 02/05/1992 | EP0469036A1 Composition and treatment with biologically active peptides and antibiotic. |
| 02/05/1992 | EP0468998A1 Peptides having novel polar n-terminal groups |
| 02/05/1992 | EP0403597A4 Expandable, protein-based, low-calorie compositions |
| 02/05/1992 | EP0191772B1 Acid-cleavable compound |
| 02/04/1992 | WO1992002619A1 Plasmid for use in producing inflamed region derived phospholipase a2 inhibitory protein, microbial cell, and production and use of said protein |
| 02/04/1992 | WO1992002617A1 Use of crosslinked crystals as a novel form of enzyme immobilization |
| 02/04/1992 | WO1992002547A1 Method for treating immune system dysfunctions |
| 02/04/1992 | WO1992002245A1 Treatment of human lactation failure |
| 02/04/1992 | US5086165 Inhibitors of retroviral protease with a ketomethylene isosteric replaced amide bond |
| 02/04/1992 | US5086164 Novel methods and compositions for treatment of angiogenic diseases |
| 02/04/1992 | US5086069 Anti-thrombotic peptide and pseudopeptide derivatives |
| 02/04/1992 | US5086042 Capable of stimulating contraction of gall bladder; having six to nine amino acids with sulfonated tyrosine and C-terminal amides; treating obesity |
| 02/04/1992 | US5086041 Methods of using prolonged release somatotropin compositions |
| 02/04/1992 | US5086040 Novel dermatological composition and method |
| 02/04/1992 | US5086039 Pharmaceutical compositions and use thereof in treating inflammation |
| 02/04/1992 | US5085990 Teicoplanin-like derivatives |
| 02/04/1992 | US5085867 Method for treating gastric ulcer with sulglycotide and hydrophilic polymer |
| 02/04/1992 | US5085851 Dental plaque-degrading compositions |
| 02/04/1992 | CA2088679A1 Method for treating immune system dysfunctions |
| 02/04/1992 | CA2067237A1 Plasmid and microbial cell for production of an inhibitory protein for phospholipase a2 from inflammatory sites, and the production and use of said protein |
| 02/04/1992 | CA1295245C Stable formulation of biologically active proteins for parenteral injection |
| 02/04/1992 | CA1295244C Treatment of actinic keratoses with alpha interferon |
| 02/04/1992 | CA1295243C Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
| 02/04/1992 | CA1295242C FORMULATIONS SUITABLE FOR THE STABILISATION OF .alpha.-INTERFERON |
| 02/04/1992 | CA1295241C Lymphokine and its production and uses |
| 02/04/1992 | CA1295240C Biologically stable interferon compositions |
| 02/04/1992 | CA1295239C Pharmaceutical administration systems containing a mixture of immunomodulators |
| 02/04/1992 | CA1295238C Methods and materials for use in corneal wounds |
| 02/03/1992 | WO1992002817A1 Adhesion receptors for pathogenic or opportunistic microorganisms |
| 02/03/1992 | WO1992002628A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 02/03/1992 | WO1992002253A1 INTERLEUKIN-4 AND INTERLEUKIN-1β SYNERGISTICALLY INDUCE VCAM-1 |
| 02/03/1992 | WO1992002251A1 Herpes simplex virus vp16 vaccines |
| 02/03/1992 | CA2088599A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 02/03/1992 | CA2066174A1 Process for the enzymatic preparation of basic fibroblast growth factor |
| 02/01/1992 | WO1992002545A1 Bombesin antagonists |
| 02/01/1992 | CA2088166A1 Peptides |
| 01/31/1992 | WO1992002244A1 Accumulation of amino acids and peptides into liposomes |
| 01/31/1992 | CA2087965A1 Accumulation of amino acids and peptides into liposomes |
| 01/30/1992 | DE4023699A1 Neue proteine, ihre herstellung und verwendung New proteins, their production and use |
| 01/29/1992 | EP0468946A1 Enzymatic method of determining beta-lactam ring antibiotics |
| 01/29/1992 | EP0468764A1 Method for administering a therapeutic anticoagulant |
| 01/29/1992 | EP0468641A2 Renin inhibiting dipeptide derivatives, their preparation and pharmaceutical preparations containing them |
| 01/29/1992 | EP0468601A1 Methods and materials for HIV detection and therapy |
| 01/29/1992 | EP0468504A1 A novel antibiotic, balhimycin, a process for its production and its use as pharmaceutical |
| 01/29/1992 | EP0468497A2 Peptide-antagonists of bombesin/GRP |
| 01/29/1992 | EP0468448A2 Analogs of hirudin having antiplatelet activity |
| 01/29/1992 | EP0468441A1 Use of particular compounds for manufacture of pharmaceutical formulations for metabolic treatments |
| 01/29/1992 | EP0468411A2 A mutant of bacterium Clostridium histolyticum, a process for the obtaining thereof, and its use in the production of clostripain-free collagenase |
| 01/29/1992 | EP0468393A1 Process for the extraction and purification of human recombinant gamma interferon |
| 01/29/1992 | EP0468339A2 Alpha-keto-amide derivatives having protease inhibiting activity |
| 01/29/1992 | EP0468337A1 DNA coding for a human vasoconstrictive peptide and use thereof |
| 01/29/1992 | EP0468327A2 Oral pharmaceutical compositions containing hirudin |
| 01/29/1992 | EP0468257A1 Multimeric form of human rhinovirus receptor protein |
| 01/29/1992 | EP0468182A1 Pharmaceutical composition in powder form for nasal administration containing essentially calcitonin and a water-soluble excipient |
| 01/29/1992 | EP0468181A2 Process for the purification of factor VIII and factor VIII obtained by said process |
| 01/29/1992 | EP0468049A1 Monoclonal antibodies for recognizing a peptide linked to a major histocompatibility antigen |
| 01/29/1992 | EP0467987A1 Methods and materials for expression of human plasminogen in a eukaryotic cell system |
| 01/29/1992 | EP0467957A1 Mercapto-acylamino acids |
| 01/29/1992 | EP0467954A1 Preparation of liposome and lipid complex compositions. |
| 01/29/1992 | EP0467932A1 Urokinase-type plasminogen activator receptor |
| 01/29/1992 | EP0467888A1 Treatment and prevention of oral mucositis with growth factors |
| 01/29/1992 | CN1058149A Stabilized fibroblast growth factor composition |
| 01/28/1992 | WO1992002542A1 Peptides and pharmaceutical compositions having glycoprotein hormone agonistic or antagonistic activity |
| 01/28/1992 | WO1992002240A2 Novel methods and compositions for treatment of angiogenic diseases |
| 01/28/1992 | US5084558 Hemoglobin solution formed by fraction of blood, separation and crosslinking |
| 01/28/1992 | US5084555 Anticarcinogenic agents, gastrointestinal disorders and diabetic agents |
| 01/28/1992 | US5084444 Anticoagulants and enzyme inhibitors |
| 01/28/1992 | US5084443 Promoting expression of acetylcholine receptors with lhrh antagonist |
| 01/28/1992 | US5084442 Cyclic polypeptides as growth hormones |
| 01/28/1992 | US5084391 Monoclonal antibody to the interleukin-2-receptor and its use |
| 01/28/1992 | US5084275 Processes of preparing α-amylase inhibiting subtances from wheat |
| 01/28/1992 | US5084274 Inhibition of arterial thrombotic occlusion or thromboembolism |
| 01/28/1992 | US5084273 Composition of anticoagulants |
| 01/28/1992 | CA2088162A1 Peptides and pharmaceutical compositions having glycoprotein hormone agonistic or antagonistic activity |
| 01/28/1992 | CA2082804A1 Methods and compositions for treatment of angiogenic diseases |
| 01/28/1992 | CA2047388A1 Aeromonas salmonicida |
| 01/28/1992 | CA1295087C Purification of recombinant beta-interferon incorporating rp-hplc |
| 01/28/1992 | CA1295085C Heptanoyl-glu-asp-ala-amino acid immunostimulants |
| 01/28/1992 | CA1294879C Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone dna, and a method for administering bgh in vivo |
| 01/28/1992 | CA1294874C Composition for inhibiting tumor growth |
| 01/28/1992 | CA1294873C Method of regulating animal reproduction |
| 01/28/1992 | CA1294872C Human complement factors and their therapeutic use |
| 01/27/1992 | WO1992001786A1 Portable ribozyme cassettes, dna sequences containing them, ribozymes encoded by these dna sequences, and compositions containing these ribozymes |
| 01/27/1992 | CA2088154A1 Portable ribozyme cassettes, dna sequences containing them, ribozyme encoded by these dna sequences, and compositions containing these ribozymes |
| 01/26/1992 | WO1992001787A1 Binding domains |
| 01/26/1992 | WO1992001465A1 Interleukin 8 inhibition of cytokine-induced histamine release from bosophils or mast cells |
| 01/26/1992 | CA2087979A1 Interleukin 8 inhibition of cytokine-induced histamine release from bosophils or mast cells |
| 01/26/1992 | CA2087095A1 Binding domains |
| 01/26/1992 | CA2047769A1 Process for the extraction and purification of human recombinant gamma interferon |
| 01/25/1992 | WO1992001712A1 Analogs of hirudin |
| 01/25/1992 | WO1992001711A1 Polypeptide compounds having growth hormone releasing activity |